DICE Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Industry
Pharmaceutical Preparations
Location
400 East Jamie Court, Suite 300, South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 11/5/2023

DICE Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Northpond Ventures GP, LLC 10%+ Owner $37.2M Jun 22, 2023
James Scopa Director Aug 9, 2023
Kevin Judice CEO, Director Aug 9, 2023
Scott M. Robertson Cfo & Cbo Aug 9, 2023
Jake Simson Director Aug 9, 2023
Timothy Lu Cmo Aug 9, 2023
Shaan-Chirag C. Gandhi Director Sep 14, 2021
Stephen Zachary Director Sep 14, 2021
Mittie Doyle Director Aug 9, 2023
Ra Capital Management, L.P. Former 10% owners and Director Aug 9, 2023
Sharon Tetlow Director Aug 9, 2023
John R. Jacobsen Cso Aug 9, 2023
Richard Scheller Director Aug 9, 2023
Lisa Bowers Director Aug 9, 2023

Recent Insider Transactions by Companies or Individuals for DICE Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.